Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.
2.
3.

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.

Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, Rossing P, Tarnow L.

Semin Nephrol. 2004 Mar;24(2):147-57. Review.

PMID:
15017527
4.
5.

Dual blockade of the renin-angiotensin system in diabetic nephropathy.

Wade VL, Gleason BL.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1278-82. Epub 2004 Jun 8. Review.

PMID:
15187210
6.
7.
8.
9.

New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease.

Ruilope LM.

J Renin Angiotensin Aldosterone Syst. 2000 Jun;1(2 Suppl):S29-31. Review.

PMID:
17199217
11.

Valsartan and the kidney: present and future.

Mann JF.

J Cardiovasc Pharmacol. 1999;33 Suppl 1:S37-40; discussion S41-3. Review.

PMID:
10028953
12.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

13.

The reno-protective effect of the dual blockade of the renin angiotensin system (RAS).

Luno J, Praga M, de Vinuesa SG.

Curr Pharm Des. 2005;11(10):1291-300. Review.

PMID:
15853685
14.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
15.

The role of angiotensin II receptor antagonists in the management of diabetes.

Barnett AH.

Blood Press Suppl. 2001;1:21-6. Review.

PMID:
11333010
16.

[Angiotensin II receptor blockers: current status and future prospects].

Corvol P, Plouin PF.

Drugs. 2002;62 Spec No 1:53-64. Review. French.

PMID:
12036389
17.

Pharmacologic management of diabetic nephropathy.

Vivian EM, Rubinstein GB.

Clin Ther. 2002 Nov;24(11):1741-56; discussion 1719. Review.

PMID:
12501871
18.

Renal and cardiovascular protection in type 2 diabetes mellitus: angiotensin II receptor blockers.

Deferrari G, Ravera M, Deferrari L, Vettoretti S, Ratto E, Parodi D.

J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S224-9. Review.

19.
20.

Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.

Jerums G, Allen TJ, Gilbert RE, Hammond J, Cooper ME, Campbell DJ, Raffaele J.

J Diabetes Complications. 1995 Oct-Dec;9(4):308-14. Review.

PMID:
8573754

Supplemental Content

Support Center